This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations cross immunotherapies, precision medicine, cancer treatment, cell engineering, liquid biopsy and AI-enabled drug discovery and development. The TOE also highlights recent advances in implantables, ophthalmology, neuropathic pain treatment and RNA modulation.



The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.



The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.



Keywords: T Cell Engineering, Immunological Disease, Cancer, Solid Tumor, Autoimmune Disease, Circulating Protein, Membrane Protein, Sustained Release, Hypoparathyroidism, ADC, Antibody Drug Conjugate, Engineered Micro-pancreas, Implantables, Immuno-oncology, Neutrophil, Precision Oncology, TYK2 Inhibitor, In-vivo Cell Engineering, Liquid Biopsy, Machine Learning, Ovarian Cancer, ALS, Precision Medicine, RNA Modulation, Speciality Clinic, Pilocarpine, Ophthalmology, Neuropathic Pain, AI-enabled Drug Discovery, Endocrine Therapy, Automated Biomanufacturing, iPSC